The UK's biotech industry according to the UK BioIndustry Association (BIA) saw investment of £1.13bn last year, positioning the UK as moving towards being the world's third largest biotech centre for life sciences.
The UK Bioscience sector along with Switzerland represents over 55% of the European total venture capital investments. Driven by the demand worldwide from aging populations there is a great demand for improved healthcare and drug therapies to combat age related illness' and conditions such as Parkinson's Disease, Vascular Dementia and Alzheimer's.
It's good to hear that the biotech industry see's the UK in a very robust position going forward despite the uncertainties of Brexit, but compared to investments across the world- America Boston-£1.6bn and San Francisco-£1.5bn there is no place to complacent.
It is important that the Universities and Biotech companies make sure that the UK is an attractive place to study, research and invest not just for home grown talent but those from across the world wanting to be at the center of academic learning and commercial development.